EIKN

Conviction 43HealthcareScan · Thu, Jun 25, 2026

EIKN$9.86+2.39%

ResistanceSupportVol 14

Vol MA14 264.67K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Eikon Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.eikontx.com ↗

Price9.86

Change+2.39%

Gap+3.27%

Rel volume2.18×

Avg volume283.64K

Avg $ vol2.72M

SMA 209.47

SMA 5010.19

SMA 200—

Price vs 50-3.26%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 11.18

RSI (14)51

MACD hist0.12

MACD crossbull · 4d

Stoch %K / %D67 / 69

ADX (14)13

+DI / −DI24 / 16

RSI divergence—

MACD divergence—

ATR %+9.19%

ADR %8.70%

52w high16.26

52w low8.36

From 52w high-39.36%

Above 52w low+17.94%

New 52w highNo

SqueezeOff

Bollinger width27.59%

%B0.65

Donchian pos55.06%

Donchian high11.37

Donchian low8.01

AVWAP (52w high)12.14

vs AVWAP high-18.80%

AVWAP (52w low)10.32

vs AVWAP low-4.45%

OBV trendFlat

Chaikin MF (20)-0.20

Today vs 20d2.18×

Avg vol (14d)264.67K

Avg vol (20d)283.64K

Avg $ vol (20d)2.72M

Market cap533.81M

RS 3m (vs SPY)-25.19%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank38.4

1 week+1.34%

1 month-0.40%

3 months-10.93%

6 months—

1 year—

YTD-34.27%

P/E—

P/B0.97

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current11.75

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value372.65M

Revenue—

Net income-82.96M

Gross profit—

Free cash flow—

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out54.14M

Employees384

ListedThu, Feb 5, 2026

Free float26.6M

Float %49.1%

Short interest4.07M

Days to cover10.3d

Short volume57.3%

Squeeze score82 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction43 / 100

Pattern quality—

Tech rank38.4 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance12.50

Support8.48

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in EIKN

All disclosures →

No recent disclosed trades by Congress in EIKN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in EIKN

No recent insider (Form 4) filings in EIKN. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in EIKN · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.